Binx Health (formerly Atlas Genetics) is a diagnostics company providing in vitro Point-of-Care (POC) testing. Its focus is on diseases such as sexually transmitted infections (STIs), neonatal sepsis and hospital acquired infections. The Company offers the ultra-rapid io™ diagnostic platform, a multi-assay system that uses disposable cartridges in conjunction with a small, low cost instrument. Its aim is to provide a flexible instrument and disposable cartridge system capable of performing nucleic acid, immunoassay and clinical chemistry diagnostics using the same technology platform.
Type | Private | |
Founded | 2005 | |
HQ | Trowbridge, GB | Map |
Website | mybinxhealth.com |
Founding Date | 2005 |
Binx Health total Funding | $214.6 m |
Binx Health latest funding size | $104 m |
Time since last funding | a year ago |
Binx Health investors | Johnson & Johnson Development Corporation, BB Biotech Ventures, Novartis Venture Fund, Global Life Science Ventures, Life Sciences Partners, South West Ventures Fund, Consort Medical, YFM Equity Partners, OrbiMed, LSP, RMI Partners, Wondfo Biotech, ArrowMark Partners, Alta Life Sciences, Parian Global, Hildred Capital Management |
GBP | |
---|---|
Revenue (FY, 2018) | 560.5k |
Net income (FY, 2018) | (17.4m) |
EBIT (FY, 2018) | (15.3m) |
Cash (31-Dec-2018) | 11.1m |
GBP | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 152.5k | 148.5k | 223.3k | 8.1k | 211.6k | 646.6k | 373.5k | 1.6m | 560.5k |
Depreciation and amortization | 316.4k | 477.8k | 402.7k | 378.7k | |||||
EBIT | (995.9k) | (357.1k) | (1.5m) | (3.3m) | (6.2m) | (7.0m) | (8.3m) | (8.6m) | (15.3m) |
EBIT margin, % | (653%) | (240%) | (681%) | (40042%) | (2952%) | (1086%) | (2213%) | (534%) | (2727%) |
GBP | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|---|---|---|
Cash | 305.7k | 104.7k | 8.1m | 5.4m | 4.9m | 1.7m | 8.7m | 2.9m | 22.3m | 11.1m |
Accounts Receivable | 9.9k | 20.4k | 1.6k | 6.3k | 1.2k | |||||
Current Assets | 341.6k | 161.6k | 8.2m | 5.6m | 5.3m | 3.1m | 10.3m | 4.5m | 24.4m | 13.6m |
GBP | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|
Cash From Operating Activities | (5.7m) | (5.5m) | (5.3m) | (6.6m) | (10.6m) |
Cash From Investing Activities | (564.2k) | (525.1k) | (449.5k) | (1.1m) | (470.3k) |
Cash From Financing Activities | 2.9m | 13.0m | 27.1m | 2.4k | |
Net Change in Cash | (3.3m) | 7.0m | (5.7m) | 19.4m | (11.1m) |
Binx Health has 163 Twitter Followers. The number of followers has increased 1.7% month over month and increased 7.8% quarter over quarter
128
Tweets
72
Following
163
Followers
15
Tweets last 30 days
3.4
Avg. likes per Tweet
86.7%
Tweets with engagement
When was Binx Health founded?
Binx Health was founded in 2005.
Who are Binx Health key executives?
Binx Health's key executives are Jeff Luber, Marc Jones and Anna Dixon.
How many employees does Binx Health have?
Binx Health has 90 employees.
What is Binx Health revenue?
Latest Binx Health annual revenue is £560.5 k.
What is Binx Health revenue per employee?
Latest Binx Health revenue per employee is £6.2 k.
Who are Binx Health competitors?
Competitors of Binx Health include Biop Medical, Cerascreen and Lansion.
Where is Binx Health headquarters?
Binx Health headquarters is located at Derby Court, Epsom Square, Trowbridge.
Where are Binx Health offices?
Binx Health has offices in Trowbridge and Cambridge.
How many offices does Binx Health have?
Binx Health has 2 offices.
Receive alerts for 300+ data fields across thousands of companies